Efmoroctocog alfa Completed Phase 4 Trials for Hemophilia A With Inhibitors Treatment
Indications | Status | Purpose | Phase |
---|---|---|---|
Completed | Treatment | 4 |
clinicaltrials.gov Identifier | Title | Drugs |
---|---|---|
NCT03093480 | A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study) |